Mostrar el registro sencillo del ítem

Artículo

dc.creatorBalcerzyk, Marcines
dc.creatorFernandez-Maza, Lauraes
dc.creatorMínguez, Juan Josees
dc.creatorMiguel Rodríguez, Manuel dees
dc.date.accessioned2023-02-06T16:03:04Z
dc.date.available2023-02-06T16:03:04Z
dc.date.issued2018
dc.identifier.citationBalcerzyk, M., Fernandez-Maza, L., Mínguez, J.J. y Miguel Rodríguez, M.d. (2018). Preclinical [18F]tetrafluoroborate-PET/CT imaging of pituitary gland hyperplasia. Japanese Journal Of Clinical Oncology, 48 (2), 200-201. https://doi.org/10.1093/jjco/hyx189.
dc.identifier.issn0368-2811es
dc.identifier.urihttps://hdl.handle.net/11441/142480
dc.description.abstractBy blocking of sodium–iodide symporter (NIS) in thyroid gland with potassium perchlorate administered in drinking water to rats for 18 months, we provoke hyperplasia of thyroid which led to thyroid cancer, but also of hyperplasia (benign tumour) of pituitary gland since the lack of thyroid hormones, as a consequence of NIS blockage, hyper-stimulates pituitary in order to produce more thyrotropin stimulating hormone (TSH), the hormone that stimulates thyroid for hormone secretion. There is evidence that hyperplasia of pituitary is provoked by perchlorate or estradiol benzoate in animal models. NIS is expressed in pituitary at the level of about one-tenth of that in thyroid. [18F]tetrafluoroborate ([18F]TFB), which mimics iodine, is a large mononegative anion that binds specifically to NIS. TFB-SUVmax (maximum Standard Uptake Value in the volume of interest, g/mL) in PET is correlated with NIS expression in thyroid.es
dc.formatapplication/pdfes
dc.format.extent2 p.es
dc.language.isoenges
dc.publisherOxfordes
dc.relation.ispartofJapanese Journal Of Clinical Oncology, 48 (2), 200-201.
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titlePreclinical [18F]tetrafluoroborate-PET/CT imaging of pituitary gland hyperplasiaes
dc.typeinfo:eu-repo/semantics/articlees
dcterms.identifierhttps://ror.org/03yxnpp24
dc.type.versioninfo:eu-repo/semantics/publishedVersiones
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Fisiología Médica y Biofísicaes
dc.contributor.affiliationUniversidad de Sevilla. Departamento de Citología e Histología Normal y Patológicaes
dc.relation.publisherversionhttps://academic.oup.com/jjco/article/48/2/200/4797535#google_vignettees
dc.identifier.doi10.1093/jjco/hyx189es
dc.journaltitleJapanese Journal Of Clinical Oncologyes
dc.publication.volumen48es
dc.publication.issue2es
dc.publication.initialPage200es
dc.publication.endPage201es

FicherosTamañoFormatoVerDescripción
Preclinical...pdf242.5KbIcon   [PDF] Ver/Abrir  

Este registro aparece en las siguientes colecciones

Mostrar el registro sencillo del ítem

Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como: Attribution-NonCommercial-NoDerivatives 4.0 Internacional